William Annett

2017

In 2017, William Annett earned a total compensation of $1.2M as President and Chief Executive Officer at Oncocyte Corp, a 14% increase compared to previous year.

Compensation breakdown

Bonus$40,000
Option Awards$740,276
Salary$397,308
Other$13,500
Total$1,191,084

Annett received $740.3K in option awards, accounting for 62% of the total pay in 2017.

Annett also received $40K in bonus, $397.3K in salary and $13.5K in other compensation.

Rankings

In 2017, William Annett's compensation ranked 8,138th out of 14,666 executives tracked by ExecPay. In other words, Annett earned more than 44.5% of executives.

ClassificationRankingPercentile
All
8,138
out of 14,666
45th
Division
Manufacturing
3,067
out of 5,772
47th
Major group
Chemicals And Allied Products
1,013
out of 2,075
51st
Industry group
Drugs
796
out of 1,731
54th
Industry
In Vitro and In Vivo Diagnostic Substances
27
out of 72
63rd
Source: SEC filing on July 27, 2018.

Annett's colleagues

We found three more compensation records of executives who worked with William Annett at Oncocyte Corp in 2017.

2017

Mitchell Levine

Oncocyte Corp

Chief Financial Officer

2017

Kristine Mechem

Oncocyte Corp

VP of Marketing

2017

Lyndal Hesterberg

Oncocyte Corp

Senior VP of Research and Development

News

In-depth

You may also like